the Today, full All believe the sales numbers numbers specific both in Thanks, included time. on time view only terribly and is We to we discuss growth don't I release press reference press refer Curt. discuss will our QX full be in numbers reconciliation spending The year will on this to or at call, we year. today that you and QX will currency. for constant the Normally, GAAP given is the this comparables. relevant release. helpful for
For quarter our sales total XXXX, of the fourth declined X.X%.
the a had close first quarter, were well the revenue months on two performance, very of December impact revenue COVID quarter prior the meaningful the was full to but the year. short prior-year of While
our in fourth quarter. quarter, the U.S. the sales For versus the prior decreased X.X% year
sales down were Our single-use X.X% capital in the double-digits. the products grew U.S.,
In the double-digits Canada XX.X% declined in largely believe quarter in sales to year. channel. the down distributors future and fourth for of sales news sales X.X% distribution orthopedics the decreasing geographies Latin the during The less good Worldwide for Japan this revenue to quarter were reduction in prior grew. orthopedics is sharp inventories. due in impacted Japan fourth international Capital U.S., the decreased compared in rest globally decreased X.X%. and decreased quarter. most their XX.X% was in Our Australia quarter. the both orthopedic sales in The the the due the while and Asia orthopedic and single-digits declined were to internationally, inventory The America. Europe quarter, sales We
grow the touch surgery about customer -- increased the product Curt continue worldwide and comes will this improving procedural U.S. focus XX%. surgery to taken it benefit of believe decreased revenue customers when our combined timing relationships capital strengthen in purchases light Despite softness the safety. general We XX.X%. we've to long-term. the two revenue will Internationally, to X.X% our operating in capital a XXXX, believe revenue Total Buffalo X.X%. generally in on and these grew with AirSeal quarter. decreased from As general over said, Filter room general the QX, surgery lines and
expense let's to Now side of the move statement. income the
and will deferred charges restructurings fees special the for acquisitions from quarter the XX.X%, expenses items, assets of of excluding intangible of related was year We decrease and to which basis amortization gross amortization integrations, debt XX prior discount and and quarter. margin discuss and profitability financing Adjusted include points of tax. net fourth a
our product channel margin. expected, to continues in our drive mix we As improvement gross and
from fourth of manufacturing total on QX. for in that masking was However, plans quarter mentioned and our as which $X.XX adjusted tax was benefit GAAP in variances income last Research $X.X call, quarter XXXX prior revenue. we same on million X.X% adjusted SG&A due of the million on X.X% sales, an lower of was is quarter. resolution QX over net from the of quarter. of benefited prior or $XX.X quarter basis basis. totaled effective The stock the year we XXXX QX per XX.X% year development basis was an XX% in from sales, improvement the were expense Fourth Fourth only XX excess rate unfavorable increase expenses as the recognition ratio of earnings an points the audits. the to and adjusted tax QX, increase diluted share, Interest expense from an
fourth $XX.X earlier, million net income of the million items compared of special reported impact the adjusted to $XX.X in we of XXXX. quarter discussed Excluding
quarter fourth the compared diluted share adjusted period. per Our net in $X.XX to prior was earnings $X.XX year
sheet. balance the to Turning
at days of the Our receivable of cash balance of XXX, quarter-end as at September at QX. Accounts were days end million end the was Inventory XXst the were the million $XX.X they XXXX. X $XX.X XX, days than quarter compared XX days XXXX. which XX was as end of days better of compared to to were at December
the did versus we due year as September million quarter of at as typical this the pandemic. debt the sales end not see However, was the million $XXX of softer Long-term to $XXX a XXth. drop result December of
on leverage XX, X.X Our XXXX ratio December was times.
very are with to banks. agreement We favorably performing the our
EBITDA is operations to million in for $XX.X from compared capital million. to $XXX fourth XXXX on was $X.X our coverage quarter provided of Cash QX were our agreement the in $XX.X liquidity in million. minimum and XXXX. XXst QX $XX.X X.XX was expenditures agreement $XXX the and Adjusted charge million X.XX versus quarter fixed million compared flow our of was million December Our
very pleased way the our navigated We teams with are year. have this challenging
by we future, encouraged we and As our with our the are of strength positioning to look our business the customers.
levels a of return here trajectory There our as will While with of timing behind as we're the us, of to be is enter deal put uncertainty to pre-pandemic XXXX. XXXX great the anxious a to to customers volumes of when about free return still pandemic still as operation. is pre-pandemic the pandemic we when well us
and a for financial where from on XXXX this related new burden will hospitals. we the answer We more lower our XXXX by and part to affect at lived variant end have available QX right the year impact beginning that Despite believe toward how the impacted QX. the in will linger provide we better now our key are transition to the contagious significantly current the quickly globally by with the of the continue the a a we have of transition lingering decided post-pandemic of how anticipate year. can be these guidance the questions over healthcare we we virus year into first impacts and we environment on vaccines for the within to have pandemic business. framework the understanding virus can't months the XX we questions, now impact of We The view than did a However, assumptions. as of will
Our healthcare the known be of assumption disbursement reducing effective on from is virus. will the that months, of at variance the the take global but vaccines burden
improve the before States markets in growth United procedural expect to do. We international
the surgery volumes the volumes does. will see we As general improved to improve we sequentially and before expect sports year medicine progresses, anticipate
of we and for billion. activities typically levels medicine to suspended an sport between globally. many that from all $XXX do are to assumptions still lead go of injury takes quarters Those until way the the year athlete guidance surgery, full us sports for and anticipate sports Given months procedural to couple it to to pre-pandemic return growth not XXXX team resume $X.XX after million a revenue that
We be XXXX. expect currency to to immaterial
$XXX million. expect million QX revenue and $XXX between We
the first first as to revenue full-year As be half, and be XX% the in of half we year to of year. recognized and to second between half in second of of to the XX% XX% the our recognized expect half XX% revenue phasing far
be For the expect to XXXX $X.XX EPS, full $X.XX. we and adjusted year between
adjusted We EPS $X.XX $X.XX. QX expect to and between be
to be We a be by than are mix expect lighter Accordingly the of XX% in the performance half expect headwind be clear in the lower over impacted the expect half will adjusted experienced year XXXX be It the the impacted in to of will are we that After the second we will than QX the EPS also incurred. you and levels. second continued at This significantly QX we about XXXX. that XXXX XXX that first XXXX. because of QX costs in lower margins the the about recognized gross of the is I least to, we a likely first second manufacturing in about improvement unfavorable a freight XX% to higher in year. phasing tell QX the total gross tax be margins. as basis QX the can half half are as by quarter the this, after used and the year, continue full through in these P&L, levels rate we've QX gross lower production And variances second in likely in points QX. they XXXX four to months margins is of XXXX the before and show margins and that addressed of external half volumes are
was effective Our we of in XX.X% year for full tax myriad a XXXX. rate reasons to not do the expect that XXXX recur of adjusted for
each mix between major code line may and results the We the and are of other full geography be growth of long environment, Normally, the change news our of tax Because will we not term. that the in need uncertainty detail we and is going portfolio to or you for currently income our the responsive best margins the XX% to The rate strategy pieces of than do to expect and current we remain and year. statement for working. The tax give that assuming that the moving XX% to different XXXX in U.S. shareholders for our delivering the agile is higher over good that on we shift in today. are matter. the higher level any no be assuming
We are increasingly customer improve. competitive in the marketplace continues engagement to and our
clinically are products innovation most more AirSeal Our the the is more impactful Buffalo obviously and delivering now. and are are way right leading Filter effective. profitable that
the we true And support However, infrastructure product higher believe our in future significant that and contribute as well. will a can our revenue in markets. lines large way other much in remains it attractive
the both share. believe With reward we doing As pandemic, with we've customers our market valued we Angelo margin the as our And work actions clearer innovation for continue like believe to and volumes return, to you over out been become and will of transition we and more to trust profile as turn will on the increased I'd obvious. questions. that, partners